文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Relationship Between Acute SARS-CoV-2 Viral Clearance and Long COVID-19 (Long COVID) Symptoms: A Cohort Study.

作者信息

Herbert Carly, Antar Annukka A R, Broach John, Wright Colton, Stamegna Pamela, Luzuriaga Katherine, Hafer Nathaniel, McManus David D, Manabe Yukari C, Soni Apurv

机构信息

Program in Digital Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

University of Massachusetts Center for Clinical and Translational Science, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

出版信息

Clin Infect Dis. 2025 Feb 5;80(1):82-90. doi: 10.1093/cid/ciae539.


DOI:10.1093/cid/ciae539
PMID:39692474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11797388/
Abstract

BACKGROUND: The relationship between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral dynamics during acute infection and the development of long coronavirus disease 2019 (COVID-19), or "long COVID," is largely unknown. METHODS: Between October 2021 and February 2022, 7361 people not known to have COVID-19 self-collected nasal swab samples for SARS-CoV-2 reverse-transcription polymerase chain reaction testing every 24-48 hours for 10-14 days. Participants whose first known SARS-CoV-2 infection was detected were surveyed for long COVID in August 2023. Their slopes of viral clearance were modeled using linear mixed effects models with random slopes and intercepts, and the relative risk (RR) of long COVID based on viral slopes was calculated using a log binomial model, adjusted for age, symptoms, and variant. Sex-based interaction terms were also evaluated for significance. RESULTS: A total of 172 participants were eligible for analyses, and 59 (34.3%) reported long COVID. The risk of long COVID with 3-4 symptoms (adjusted RR, 2.44 [95% confidence interval, .88-6.82]) and ≥5 symptoms (4.97 [1.90-13.0]) increased with each unit increase in slope of viral clearance. While the probability of long COVID increased with slowed viral clearance among women, the same relationship was not observed among men (interaction term: P = .02). Acute SARS-CoV-2 symptoms of abdominal pain (adjusted RR, 5.41 [95% confidence interval, 2.44-12.0]), nausea (3.01 [1.31-6.89]), and body aches (2.58 [1.26-5.30]) were most strongly associated with long COVID. CONCLUSIONS: We observed that slower viral clearance rates during acute COVID-19 were associated with increased risk and more symptoms of long COVID . Early viral-host dynamics appear to be mechanistically linked to the development of long COVID.

摘要

相似文献

[1]
Relationship Between Acute SARS-CoV-2 Viral Clearance and Long COVID-19 (Long COVID) Symptoms: A Cohort Study.

Clin Infect Dis. 2025-2-5

[2]
Antibody tests for identification of current and past infection with SARS-CoV-2.

Cochrane Database Syst Rev. 2022-11-17

[3]
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.

Cochrane Database Syst Rev. 2022-7-22

[4]
Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection.

Cochrane Database Syst Rev. 2024-10-14

[5]
Physical interventions to interrupt or reduce the spread of respiratory viruses.

Cochrane Database Syst Rev. 2023-1-30

[6]
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.

Cochrane Database Syst Rev. 2022-9-20

[7]
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.

Cochrane Database Syst Rev. 2022-5-20

[8]
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.

Cochrane Database Syst Rev. 2023-11-30

[9]
Ivermectin for preventing and treating COVID-19.

Cochrane Database Syst Rev. 2022-6-21

[10]
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.

Cochrane Database Syst Rev. 2021-9-2

引用本文的文献

[1]
Long-term neurocognitive outcomes of SARS-CoV-2 infection in a hamster model.

Front Microbiol. 2025-8-14

[2]
A multinational cross-sectional study on the prevalence and predictors of long COVID across 33 countries.

Sci Rep. 2025-8-3

[3]
A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate COVID-19.

Nat Commun. 2025-8-1

[4]
Translating insights into therapies for Long Covid.

Sci Transl Med. 2024-11-13

本文引用的文献

[1]
Sex differences and immune correlates of Long Covid development, symptom persistence, and resolution.

Sci Transl Med. 2024-11-13

[2]
Early, Robust Mucosal Secretory Immunoglobulin A but not Immunoglobulin G Response to Severe Acute Respiratory Syndrome Coronavirus 2 Spike in Oral Fluid Is Associated With Faster Viral Clearance and Coronavirus Disease 2019 Symptom Resolution.

J Infect Dis. 2025-2-4

[3]
Early biological markers of post-acute sequelae of SARS-CoV-2 infection.

Nat Commun. 2024-8-29

[4]
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study.

Nat Commun. 2024-1-3

[5]
Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection.

Proc Natl Acad Sci U S A. 2023-12-26

[6]
Differential Viral Dynamics by Sex and Body Mass Index During Acute SARS-CoV-2 Infection: Results From a Longitudinal Cohort Study.

Clin Infect Dis. 2024-5-15

[7]
The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs.

Clin Infect Dis. 2024-2-17

[8]
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC).

Nat Immunol. 2023-10

[9]
Long COVID and Significant Activity Limitation Among Adults, by Age - United States, June 1-13, 2022, to June 7-19, 2023.

MMWR Morb Mortal Wkly Rep. 2023-8-11

[10]
Association Between Duration of SARS-CoV-2 Positivity and Long COVID.

Clin Infect Dis. 2023-11-30

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索